Press Releases
AstraZeneca to Supply Europe with 400M Doses of COVID-19 Vaccine
AstraZeneca has reached an agreement with Europe’s Inclusive Vaccines Alliance (IVA), spearheaded by Germany, France, Italy and the Netherlands, to supply up to 400 million doses of the University of Oxford’s COVID-19 vaccine, with deliveries starting by the end...
Drug Research
Catalent Signs Agreement with AstraZeneca to Manufacture COVID-19 Vaccine Candidate
Catalent, Inc. , the leading global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, cell and gene therapies, and consumer health products, announced that Catalent Biologics will provide vial filling and packaging capacity to AstraZeneca...
Press Releases
Illumina Receives First FDA Emergency Use Authorization for a Sequencing-Based COVID-19 Diagnostic Test
llumina, Inc. is paving the way for large-scale, next-generation sequencing-based (NGS) COVID-19 testing. The U.S. FDA issued an EUA for the Illumina COVIDSeqâ„¢ Test, a high-throughput, sequencing-based, in vitro diagnostic (IVD) workflow enabling the detection of SARS-CoV-2. The end-to-end...
Press Releases
CPhI Middle East & Africa to debut in Saudi Arabia in 2021
Informa, the organisers of the leading regional pharmaceutical event CPhI Middle East & Africa, has announced that due to the COVID-19 pandemic, the 2020 edition of the show, scheduled to take place in September in Abu Dhabi, has been...
Packaging & Labelling
CSafe Global mobile refrigeration units ensure safe transport of COVID-19 test kits
CSafe Global, the innovation leader in temperature-controlled container solutions for the transport of life-enhancing pharmaceuticals, is working with Genome LLC to ensure that their COVID-19 genetic testing kits arrive safely at Genome’s lab for analysis using CSafe’s AX56L mobile...
Clinical Trials
Lilly Announces Start of a Phase 1 Study for its Second Potential COVID-19 Antibody Treatment
Eli Lilly and Company announced its partner Junshi Biosciences has dosed the first healthy volunteer in a study of a potential neutralizing antibody treatment designed to fight COVID-19.
The investigational medicine, referred to as JS016, is being co-developed by Junshi...
Drug Research
Fujifilm to invest 100 billion yen to expand its large scale biologics production facility in Denmark
FUJIFILM Corporation will make a major capital investment of approximately 100 billion yen (928 million USD) in the Denmark site of FUJIFILM Diosynth Biotechnologies, a leading contract development and manufacturing organization (CDMO) for biologics and advanced therapies. The capital...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read